The U.S. Food and Drug Administration has approved Symbravo (meloxicam and rizatriptan) for the acute treatment of migraine ...

The American College of Physicians (ACP) has developed new recommendations to prevent episodic migraines in nonpregnant adults in outpatient settings.

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated biopharmaceutical company with marketed products and a pipeline ...

Refractory chronic cough represents a significant unmet need with no FDA-approved treatment options and $11B total ...

This information helps your health care provider tailor a treatment plan that’s most ... lifestyle factors and health issues. The chart below uses insight from studies including those conducted ...

due to episodic migraine is either 10 mg, 30 mg, or 60 mg once per day. This medication dosage is not based on body weight. Qulipta is not approved for use in children, so there are no dosage ...

to healthcare professionals to induce them to prescribe the migraine medication Nurtec ODT more often in violation of the anti-kickback statute. The scheme took place from March 1, 2020 ...

“I often advise patients to have a plan they can enact if they have migraine when they’re away from home,” says Dr. Masters-Israilov. “This includes having effective medications on hand ...

While conventional medication offers some relief, it often brings along side effects that can be as severe as the migraine itself. This is where the usefulness of CBD oil enters the picture.

Stimulant medications are considered the first-line treatment for ADHD for some very good reasons. Here are 6 things to know about stimulant medications in ADHD. Attention Deficit Hyperactivity ...